Study guide
Infectious Disease Serology
ASCP MLS Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Orientation To ASCP MLS Certification
Credential Purpose And Role ASCP BOC And Eligibility At A High Level MLS Versus MLS(ASCPi) Wording Application Fee And Transcript Result Basics CAT Exam Model Overview Study Plan From Content Guideline
2 Exam Format, CAT Scoring, And Score details
100 Questions And 2h30m Computer Adaptive Testing One-Best-Answer Multiple Choice Theoretical Versus Procedural Questions Scaled Score 100-999, Minimum 400 Score Notification Timing And Transcript Dependency
3 Blood Banking
Products And Components Blood Group Systems And Immunology Serologic And Molecular Testing Compatibility Testing And Transfusion Practice Physiology And Pathophysiology High-Yield Study Strategy
4 Chemistry
Carbohydrates, Lipids, Proteins, And Nitrogen Compounds Enzymes And Heme Derivatives Acid-Base, Blood Gases, And Electrolytes Endocrinology, Vitamins, And Nutrition Therapeutic Drug Monitoring And Toxicology Calculations And Correlation
5 Hematology And Hemostasis
Normal Hematopoiesis And Cell Morphology Anemia And RBC Disorders Leukocyte Disorders And Disease States Platelet And Coagulation Physiology Hemostasis Testing Smear, Analyzer, And Result Correlation
6 Microbiology
Preanalytic Specimen Handling Bacteriology Analytic Procedures Susceptibility And Organism Identification Logic Mycobacteriology, Virology, Parasitology, And Mycology Postanalytic Reporting Safety And Contamination Awareness
7 Urinalysis And Other Body Fluids
Physical And Chemical Urinalysis Microscopic Sediment Renal Physiology And Disease States CSF And Serous Fluids Body Fluid Cell Counts And Crystals Correlation And Preanalytic Issues
8 Immunology
Principles Of Immune Response Immune-System Diseases Infectious Disease Serology Transplantation And Compatibility Concepts Serologic Procedures And Test Methodology Interpretation Pitfalls
9 Laboratory Operations
Quality Assessment And Troubleshooting Safety Laboratory Mathematics Manual And Automated Methodology Instrumentation And Validation Management And Education Principles
10 Integrated Case Reasoning And Calculations
Correlating Patient Results To Disease States Applying Knowledge To New Facts Calculations And Units Procedural Decision-Making QA/QC In Case Questions Avoiding Memorization-Only Study
11 Practice Strategy And Remediation
Content Percentage Allocation CAT-Aware Practice Mindset Reviewing Misses By Domain Using The Official Guideline Before Third-Party Materials Transcript And Result Timing In Planning Final Remediation Cycles
12 Final Review And Exam-Day Readiness
Final-Week Schedule Timing And Pacing Score Expectations Result And Credential Next Steps Digital Badge And Documentation Post-Exam Actions Without Promises
Infectious Disease Serology
Key Takeaways Explain This Topic AI
Hepatitis B serology hinges on three markers: HBsAg (active infection), anti-HBs (immunity/recovery), and anti-HBc (exposure); IgM anti-HBc marks acute infection.
The isolated anti-HBc-positive 'window period' occurs after HBsAg clears but before anti-HBs appears.
Syphilis testing uses non-treponemal screens (RPR, VDRL) that titer with disease activity plus confirmatory treponemal tests (FTA-ABS, TP-PA) that stay positive for life.
A fourfold (two-dilution) rise in titer between acute and convalescent sera is the serologic standard for recent infection.
Last updated: November 2026
Hepatitis B Serology
No single immunology pattern is tested more than the hepatitis B virus (HBV) panel. Learn what each marker means and you can read any combination.
- Marker Meaning
- HBsAg (surface antigen) Active infection (acute or chronic); first marker to appear
- Anti-HBs (surface antibody) Recovery and immunity; also produced by vaccination
- Anti-HBc (core antibody) Past or present exposure; never from vaccine
- IgM anti-HBc Acute (recent) infection; marks the window period
- HBeAg High viral replication and high infectivity
- Anti-HBe Lower infectivity / waning replication
Interpretation logic:
HBsAg+, IgM anti-HBc+: acute hepatitis B.
HBsAg+ for >6 months, IgG anti-HBc+, HBsAg persists: chronic hepatitis B.
Anti-HBs+, anti-HBc+ (HBsAg-): resolved past infection with immunity.
Anti-HBs+ only (anti-HBc negative): vaccine-induced immunity — the cleanest exam discriminator, because vaccine contains only surface antigen, never core.
Anti-HBc+ alone (HBsAg-, anti-HBs-): the window period (HBsAg has cleared, anti-HBs not yet detectable) or a remote/occult infection.
Worked example: A healthy nurse tests anti-HBs positive but anti-HBc negative and HBsAg negative. Because the core antibody is absent, this is vaccine-induced immunity , not past natural infection.
Syphilis Serology
Syphilis (Treponema pallidum) testing pairs two test types because each has a distinct role.
Non-treponemal tests — RPR and VDRL: detect reagin (antibody to cardiolipin). They are inexpensive screens , give a quantitative titer that falls with treatment, and are used to monitor therapy. They can give biologic false positives in pregnancy, lupus, mononucleosis, and other conditions.
Treponemal tests — FTA-ABS, TP-PA, EIA: detect specific antibody to the organism, confirm a reactive screen, and usually remain reactive for life even after cure (so they cannot monitor treatment).
The traditional algorithm screens with RPR/VDRL, then confirms positives with a treponemal test. The reverse algorithm screens with a treponemal EIA first, then reflexes to RPR. A fourfold drop in RPR titer after treatment (e.g., 1:32 → 1:8) indicates adequate response.
HIV Testing
The current CDC-recommended algorithm is a fourth-generation antigen/antibody combination immunoassay that detects both p24 antigen and HIV-1/HIV-2 antibodies , shortening the diagnostic window. A reactive screen goes to an HIV-1/HIV-2 antibody differentiation immunoassay ; if that is non-reactive or indeterminate, an HIV-1 nucleic acid test (NAT) follows, and a reactive NAT indicates acute HIV-1 infection. The older Western blot confirmation has been replaced by this differentiation assay.
Other Tested Serologies And Titers
Mononucleosis (EBV): heterophile antibody (Monospot); confirmed by EBV-specific antibodies (VCA IgM = acute, EBNA = past).
Streptococcal: anti-streptolysin O (ASO) titer rises after group A strep infection (post-strep glomerulonephritis, rheumatic fever).
Rubella / TORCH: IgM = acute or congenital; IgG = immunity.
Titer rule: report the highest dilution still showing reactivity . A fourfold rise (two doubling dilutions, e.g., 1:16 → 1:64) between acute and convalescent specimens is the standard evidence of recent infection.
High-Yield Traps
Vaccine gives anti-HBs only ; natural infection adds anti-HBc .
Treponemal tests stay positive for life — use the non-treponemal titer to follow treatment, never the treponemal test.
The HBV window period is detected by IgM anti-HBc when both HBsAg and anti-HBs are negative.
A single high titer is less meaningful than a rising titer across paired sera.
Hepatitis A And C
Beyond hepatitis B, the exam expects basic interpretation of the other hepatitis viruses. Hepatitis A virus (HAV) is spread fecal-orally and causes acute, self-limited disease: IgM anti-HAV indicates acute infection, while IgG anti-HAV indicates past infection or vaccination and lifelong immunity. Hepatitis C virus (HCV) is blood-borne and frequently chronic; screening detects anti-HCV antibody by immunoassay, but because antibody cannot distinguish active from resolved infection, a reactive screen is confirmed by HCV RNA (nucleic acid) testing to prove active viremia.
This antibody-then-RNA logic mirrors the HIV algorithm and reinforces the rule that antibody alone does not prove active disease.
TORCH And Congenital Infections
The TORCH panel screens for congenital infections: T oxoplasma, O ther (syphilis, varicella, parvovirus B19), R ubella, C ytomegalovirus, and H erpes simplex. The interpretive key is the immunoglobulin class:
IgG in a newborn may be maternal (transferred across the placenta) and does not by itself prove neonatal infection.
IgM in a newborn indicates true congenital infection , because IgM does not cross the placenta.
Reading Serology In Clinical Context
Serologic interpretation is the highest-yield application skill in this domain. A practical decision sequence:
Identify the antibody class present — IgM suggests acute, IgG suggests past or immune.
Decide whether antigen or nucleic acid testing is needed to prove active disease (HBsAg, p24, HCV RNA).
For paired sera, look for a fourfold rise before calling acute infection.
Reconcile the result with the clinical picture ; if they conflict, consider technical artifacts.
Worked example: A blood donor screens reactive for anti-HCV. Because antibody persists after both active and resolved infection, the laboratory reflexes to HCV RNA : a positive RNA confirms current infection, while a negative RNA suggests cleared or resolved disease. Reporting active hepatitis C from the antibody screen alone would be an interpretive error.
Additional Traps
HAV/HCV: IgM anti-HAV = acute HAV; anti-HCV reactive needs HCV RNA confirmation.
A newborn's IgG can be maternal; only IgM proves congenital infection.
HIV uses a fourth-generation antigen/antibody screen, then a differentiation immunoassay , not Western blot.